Publications

Having previously shown that levels of the citrullinated vimentin peptide VICM are raised in liver fibrosis in rats, we aimed to investigate whether inhibition of citrullination as measured by VICM levels could affect fibrogenesis.\r\n\r\nMETHODS:\r\nFibrogenesis was evaluated by quantitative histol...

Read the publication

• Alcoholic Liver Disease
• Hepatic Diseases
• Fibrosis

Objective: Ankylosing spondylitis (AS) has been considered a seronegative rheumatic disease based on absent or low levels of antibodies against citrullinated proteins. The present study was undertaken to evaluate whether a citrullinated and matrix metalloproteinase-degraded fragment of vimentin (VIC...

Read the publication

• Ankylosing Spondylitis
• Rheumatoid Arthritis

Background: Titin is a muscle-specific protein found in cardiac and skeletal muscles which is responsible for restoring passive tension. Levels and functioning of titin have been shown to be affected by cardiac damage. Due to the inherent difficulty of measuring titin levels in vivo in a clinical se...

Read the publication

• Cardiovascular Diseases
• Myocardial Infarction

AIM:To measure levels of the collagen V formation marker CO5-1230 during liver fibrosis progression and regression.METHODS:Monoclonal antibodies were raised against the sequence TAALGDIMGH located at the start of the C-terminal propeptide between amino acid position 1230 and 1239 (CO5-1230). An assa...

Read the publication

• Alcoholic Liver Disease
• Hepatic Diseases
• Fibrosis

Aim: Liver fibrosis involves excessive remodeling and deposition of fibrillar extracellular matrix (ECM) components, which leads to malfunction of the organ, causing significant morbidity and mortality. The aim of this study was to assess whether levels of a type V collagen fragment, the propeptide ...

Read the publication

• Non-Alcoholic Fatty Liver Disease
• Fibrosis

Background: Hepatic fibrosis is characterized by intense tissue remodeling, mainly driven by matrix metalloproteinases. We previously identified CO3-610, a type III collagen neoepitope generated by matrix metalloproteinase (MMP)-9, and tested its performance as a fibrosis marker in rats with bile-du...

Read the publication

• Non-Alcoholic Steatohepatitis
• Fibrosis
• Hepatic Diseases

Aim: Arterial extracellular matrix (ECM) remodeling by matrix metalloproteinases (MMPs) is one of the major hallmarks of atherosclerosis. Mimecan, also known as osteoglycin has been implicated in the integrity of the ECM. This study assessed the validity of an enzyme-linked immunosorbent assay (EL...

Read the publication

• Cardiovascular Diseases
• Atherosclerosis

Background and aims: During fibrogenesis, in which excessive remodeling of the extracellular matrix occurs, both the quantity of type VI collagen and levels of matrix metalloproteinases, including MMP-2 and MMP-9, increase significantly. Proteolytic degradation of type VI collagen into small fragmen...

Read the publication

• Non-Alcoholic Fatty Liver Disease
• Hepatic Diseases
• Fibrosis

Objective: Degradation of collagen in the arterial wall by matrix metalloproteinases is the hallmark of atherosclerosis. We have developed an ELISA for the quantification of type III collagen degradation mediated by MMP-9 in urine. Design and methods: A monoclonal antibody targeting a specific MMP-9...

Read the publication

• Cardiovascular Diseases
• Atherosclerosis

Background: During fibrogenesis in the liver, in which excessive remodelling of the extracellular matrix (ECM) occurs, both the quantity of type III collagen (CO3) and levels of matrix metalloproteinases (MMPs), including MMP-9, increase significantly. MMPs play major roles in ECM remodelling, via t...

Read the publication

• Liver Fibrosis